Stockscreener 앱 받기
2.81
3.44%
-0.10
시간 외 거래:
2.80
-0.01
-0.36%
Longeveron Inc 주식(LGVN)의 최신 뉴스
Longeveron ELPIS II Miss, Strategic Review and Refocus - TipRanks
Longeveron reports ELPIS II misses primary endpoint; to analyze data, explore strategic options - TradingView
Longeveron starts strategic review after laromestrocel failure to improve heart function in HLHS infants - AllSci
Longeveron Shares Plunge 60% After Pediatric Stem Cell Therapy Misses Primary Goal - finance.biggo.com
Longeveron (LGVN) Heart Treatment Falls Short. Can a Strategic Review Preserve Value? - Yahoo Finance
Longeveron Stock Price Forecast. Should You Buy LGVN? - StockInvest.us
Longeveron shares plunge 59% as HLHS heart therapy misses endpoint - thepharmaletter.com
Longeveron slides 59% after-hours from stem cell therapy study failure - Mugglehead Investment Magazine
Longeveron (LGVN) Shares Slide 59% After Hours: Here's Why - webull.com
Longeveron to carry on? Shortfall in HLSH phase IIb - BioWorld News
Longeveron stock plunges 50% after trial misses primary endpoint By Investing.com - Investing.com Nigeria
Longeveron stock plunges 50% after trial misses primary endpoint - Investing.com
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS) - BioSpace
Longeveron to resume trading at 5:55 pm ET - TipRanks
Longeveron exploring all options for maximizing shareholder value - TipRanks
Longeveron explores strategic options after therapy fails mid-stage trial for infant heart condition - Yahoo Finance
Longeveron Shares Halted After Heart Therapy Trial Misses Primary Endpoint - marketscreener.com
Longeveron Announces ELPIS II Results, Reviews Strategic Alternatives to Maximize Shareholder Value - Quiver Quantitative
Logos Global Management LP Adds Longeveron Inc (LGVN) Shares -- Stock Looks 118% Overvalued on GF Value - gurufocus.com
Longeveron Regains Nasdaq Compliance With Minimum Bid Price - TipRanks
192,308 Longeveron (NASDAQ: LGVN) shares sit with one passive fund - Stock Titan
LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming DeadlineLGVN - TMX Newsfile
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
A biotech presentation is set for New York on Sept. 14 - Stock Titan
Longeveron | 4: Statement of changes in beneficial ownership of securities - Moomoo
Longeveron (LGVN) Gains 2.68% as Shares Hold Above Key Support at $6.55Breakout Confirmation - vinanet.vn
Longeveron To Carry Out 1-for-10 Reverse Stock Split On August 27th, 2026 - Moomoo
Longeveron Announces 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance - Intellectia AI
Longeveron Announces 1-for-10 Reverse Stock Split - The Manila Times
Longeveron Inc. Earnings Call: Trials, Cash and Risk - TipRanks
Longeveron (NASDAQ: LGVN) insider logs new stock trades - Stock Titan
Longeveron (LGVN) grants director 36,000 stock units - Stock Titan
Longeveron (NASDAQ: LGVN) insider reports new stock dealings - Stock Titan
Longeveron (LGVN) insider logs new stock transactions in company shares - stocktitan.net
Longeveron (LGVN) Q2 2026 Earnings Call Transcript - AOL.ca
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - The Manila Times
Longeveron (LGVN) Earnings Reading: Profit Per Share Falls Below Its Benchmark at the Close; After Results: The Stock Gains 4.46% in the Current UpdateProfitability Analysis - vinanet.vn
Longeveron appoints Nirav Jhaveri as chief financial officer - Investing.com Nigeria
Longeveron Appoints Nirav Jhaveri as CFO Ahead of September Trial Data - Minichart
symbol__ Stock Quote Price and Forecast - CNN
Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed - TipRanks
Longeveron Appoints New Chief Financial Officer Jhaveri - TipRanks
Longeveron Appoints Nirav Jhaveri As CFO - marketscreener.com
Longeveron appoints Nirav Jhaveri as chief financial officer By Investing.com - Investing.com India
Longeveron Inc. Appoints Nirav Jhaveri as Chief Financial Officer - Quiver Quantitative
Marie Washburn Net Worth (2026) - GuruFocus
Longeveron reports Q2 EPS (19c) vs. (33c) last year - TipRanks
$Longeveron (LGVN.US)$ - Moomoo
Longeveron Inc. (LGVN) investors disclose 9% beneficial stake through warrant holdings - Stock Titan
Longeveron LLC earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
3.06%
2.55%
자본화:
|
볼륨(24시간):